key: cord-0749319-curfvmmx authors: Li, Meng; Zhao, Yuwei; Li, Ying; Chen, Xue; Luo, Dongxia; Luo, Mei; Hou, Jue; Liu, Juan; Liu, Humin; Wang, Huan; Dong, Yufang; Zhang, Lanjiang; Ji, Maosheng; Zhao, Xin; Wei, Caibing; Li, Wen; Gao, Jialiang; Shan, Hua; Fu, Xuemei title: Development and Evaluation of a Novel RT‐PCR System for Reliable and Rapid SARS‐CoV‐2 Screening of Blood Donations date: 2020-08-15 journal: Transfusion DOI: 10.1111/trf.16049 sha: fab6ec6ddc3c5acf48dd6ec160e5b54496925143 doc_id: 749319 cord_uid: curfvmmx BACKGROUND: The ongoing outbreak of SARS‐CoV‐2 has caused great global concerns. In contrast to SARS, some SARS‐CoV‐2 infected people can be asymptomatic or only have mild non‐specific symptoms. Furthermore, there is evidence that SARS‐CoV‐2 may be infectious during an asymptomatic incubation period. With the discovery that SARS‐CoV‐2 can be detected in plasma or serum, blood safety is worthy of consideration. STUDY DESIGN AND METHODS: We developed a NAT screening system for SARS‐CoV‐2 targeting nucleocapsid protein (N) and open reading frame 1ab (ORF 1ab) gene which could screen 5076 samples every 24 hours. 2019‐nCoV RNA standard was used to evaluate linearity of standard curves. Diagnostic sensitivity and reproducibility were evaluated using artificial SARS‐CoV‐2 virus. Specificity was evaluated with 61 other respiratory pathogens. Diagnostic performance was evaluated by testing 2 sputum and 9 oropharyngeal swab specimens. The RT‐PCR assay was used to screen SARS‐CoV‐2 RNA in blood donors specimens collected during the outbreak of SARS‐CoV‐2 in Chengdu. RESULTS: LOD of the SARS‐CoV‐2 RT‐PCR assay for N and ORF 1ab gene were 12.5 and 27.58 copies/mL, respectively. Intra‐assay and inter‐assay for SARS‐CoV‐2 RT‐PCR assay based on Ct were acceptably low. No cross‐reactivity was observed with other respiratory virus and bacterial isolates. The overall agreement value between SARS‐CoV‐2 RT‐PCR assay and clinical diagnostic results were 100%. A total of 16 287 blood specimens collected from blood donors during SARS‐CoV‐2 surveillance were tested negative. CONCLUSIONS: A high throughput NAT screening system was developed for SARS‐CoV‐2 screening of blood donations during the outbreak of SARS‐CoV‐2. Introduction respiratory failure and multiple organ dysfunctions (MODS) [15] [16] [17] . It was established that there was about 81% SARS-CoV-2 cases with non-pneumonia and mild pneumonia 18, 19 . Chan et al reported an asymptomatic carrier in a family cluster of COVID-19 20 . SARS-CoV-2 might be infectious during an asymptomatic incubation period [21] [22] [23] [24] [25] . According to the investigations conducted by China CDC, the incubation time is generally 3 to 7 days with the mean incubation period as 5.2 days (95% confidence interval [CI], 4.1 to 7.0) and the 95th percentile of the distribution as 12.5 days 26, 27 . The incubation period of SARS-CoV-2 is longer than SARS-CoV 26,28,29 . These increase the challenge for prevention and control of SARS-CoV-2 infections. Although coronaviruses usually infect the upper and lower respiratory tract, viral shedding in blood is common 3,30, 31 . It has been demonstrated that 15%-40% of SARS-CoV-2-infected individuals have detectable RNA-emia 16, 30, 32 . Furthermore, there were no differences between ICU patients and patients with mild symptoms on median PCR cycle threshold value 16 In this study, we developed a high throughput (5076 tests per 24 hours) , high sensitivity and accurate NAT screening system for the SARS-CoV-2 RNA detection of blood donations in collaboration with Sansure Biotechnology Company. After evaluating its analytical performance and clinical applicability, the assay was used for screening SARS-CoV-2 RNA in blood specimens collected from blood donors during the height of SARS-CoV-2 epidemic in Chengdu. Virus and clinical specimens. To determine linearity of standard curve, 2019-nCoV RNA standard were Accepted Article This article is protected by copyright. All rights reserved. diluted to 6 concentrations by tenfold serial dilutions with N gene from 1.36×10 5 to 1.36 copies/mL and ORF 1ab gene from 6.89×10 4 to 0.689 copies/mL using Rnase free water. 10 replicates per dilution. The PCR efficiency (E) was calculated using the standard curve slope according the following formula: E=10 -1/slope -1. The correlation coefficient (R 2 ) was also calculated. Diagnostic performance. The diagnostic performance of the assay was evaluated by testing 11 clinical specimens (2 sputum and 9 cut-off value of 11.47 copies/mL (95% confidence interval (CI): from 8.49 to 21.14 copies/mL). The ORF 1ab assay detects 16.36 copies/mL with 95% probability (95% CI: from 12.78 to 25.06 copies/mL). negative, consistent with clinical diagnosis. The kappa coefficient between the two qualitative results was 100% (Supplementary table 2) . However, the testing results of ORF 1ab and N gene for oropharyngeal swab sample for one patient were different (Supplementary table 3, 4) . (ii) Performance of the RT-PCR assay with plasma specimens from blood donors during COVID-19 surveillance. A total of 16,287 blood specimens collected from donors between 27 January 2020 and 29 February 2020 in Chengdu were tested in mini pools of 6 and all results were negative. We also performed retrospective individual donation re-testing of 15 stored samples from donors who notified us after blood donation that they had contacted with suspected COVID-19 patients or had fever, cough or other suspected SARS-CoV-2 symptoms. All tested negative and these donors have not developed to COVID-19 patients. SARS-CoV-2 RT-PCR is widely used for clinical diagnostic purpose. Many reports have described RT-PCR assays for detection of SARS-CoV-2 RNA targeting regions of ORF 1ab and N gene [36] [37] [38] . No RT-PCR assay for blood donor screening had been reported so far. Although there has not been definitive evidence demonstrating that SARS-CoV-2 can be transmitted through blood, SARS-CoV-2 RNA has been detected in asymptomatic blood donors 33 . Some asymptomatic Accepted Article infected individuals may not be deferred by body temperature check, health history, travel/residence history or contact history during pre-donation screening. NAT technology may be helpful to detect SARS-CoV-2 virus in these potential donors 33, [39] [40] [41] . We urgently developed a NAT system to screen blood donor's sample for SARS-CoV-2 with Sansure Biotechnology Company at the early stage of SARS-CoV-2 epidemic in Chengdu. To address a potential risk of SARS-CoV-2 transmission through blood, our NAT donor screening system was used for screening blood donors in Chengdu during the epidemic period. A total of 16,287 consecutive donor blood specimens were tested. All results were negative. In contrast, a donor screening study in Wuhan found SARS-CoV-2 RNA in blood samples from four asymptomatic blood donors 34 The work has not been submitted elsewhere for publication, in whole or in part. All authors have read the manuscript and approved to submit to your journal. There is no any ethical/legal conflict involved in the article. Probit analysis of LOD for N and ORF 1ab gene in Supplementary Figure 1 . This article is protected by copyright. All rights reserved. TABLE2. Intra-and inter-assay of SARS-CoV-2 RT-PCR assay based on Ct. Accepted Article This article is protected by copyright. All rights reserved. Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak -an update on the status Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan Evaluation and Treatment Coronavirus (COVID-19) StatPearls. Treasure Island (FL) Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention Characteristics of COVID-19 infection in Beijing A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2 Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients A novel one-step single-tube nested quantitative Real-Time PCR assay for highly sensitive detection of SARS-CoV-2 Identification of a novel coronavirus in patients with severe acute respiratory syndrome Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing